Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18045731rdf:typepubmed:Citationlld:pubmed
pubmed-article:18045731lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0024501lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C1518419lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0013072lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0064494lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C1696465lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0205265lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0205197lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C1554962lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:18045731lifeskim:mentionsumls-concept:C1555582lld:lifeskim
pubmed-article:18045731pubmed:issue2lld:pubmed
pubmed-article:18045731pubmed:dateCreated2008-5-5lld:pubmed
pubmed-article:18045731pubmed:abstractTextThis study assessed whether maintenance therapy with carboxyaminoimidazole (CAI), compared to placebo, prolonged overall survival in stage IIIB/IV NSCLC patients who had tumour regression or stable disease after treatment with one chemotherapy regimen.lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:languageenglld:pubmed
pubmed-article:18045731pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:citationSubsetIMlld:pubmed
pubmed-article:18045731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18045731pubmed:statusMEDLINElld:pubmed
pubmed-article:18045731pubmed:monthMaylld:pubmed
pubmed-article:18045731pubmed:issn0169-5002lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:PerezEdith...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:WindschitlHar...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:JohnsonElizab...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:FitchTom RTRlld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:KuglerJohn...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:MarksRandolph...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:JettJames RJRlld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:HillmanShauna...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:AdjeiAlex AAAlld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:MooreDennis...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:SooriGamini...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:GrahamDavid...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:MandrekarSumi...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:WosEdward JEJlld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:BernathAlbert...lld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:HaugeMark DMDlld:pubmed
pubmed-article:18045731pubmed:authorpubmed-author:BaumanMitchel...lld:pubmed
pubmed-article:18045731pubmed:issnTypePrintlld:pubmed
pubmed-article:18045731pubmed:volume60lld:pubmed
pubmed-article:18045731pubmed:ownerNLMlld:pubmed
pubmed-article:18045731pubmed:authorsCompleteYlld:pubmed
pubmed-article:18045731pubmed:pagination200-7lld:pubmed
pubmed-article:18045731pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:meshHeadingpubmed-meshheading:18045731...lld:pubmed
pubmed-article:18045731pubmed:year2008lld:pubmed
pubmed-article:18045731pubmed:articleTitlePhase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).lld:pubmed
pubmed-article:18045731pubmed:affiliationMayo Clinic Jacksonville, Jacksonville, FL 32224, USA. johnson.elizabeth2@mayo.edulld:pubmed
pubmed-article:18045731pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18045731pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18045731pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:18045731pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed
pubmed-article:18045731pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18045731lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18045731lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18045731lld:pubmed